Trial intelligence / Profile preview

VAPOR-2: Sevoflurane vs Propofol in Kidney Transplantation

NCT02727296Phase 4Completed

Sponsor
University Medical Center Groningen
Start
Apr 2017
Primary completion
Jan 2025
Modality
Small Molecules
Countries
4
01

Overview

A Phase 4 trial of sevoflurane in delayed graft function (DGF), Acute Kidney Transplant Rejection (AR), sponsored by University Medical Center Groningen. Started Apr 2017; status: completed.

02

Drugs

sevoflurane
03

Conditions

delayed graft function (DGF)Acute Kidney Transplant Rejection (AR)

Beyond the preview

Go deeper on NCT02727296.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02727296.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call